|
1
|
Aschele C, Cionini L, Lonardi S, Pinto C,
Cordio S, Rosati G, Artale S, Tagliagambe A, Ambrosini G, Rosetti
P, et al: Primary tumor response to preoperative chemoradiation
with or without oxaliplatin in locally advanced rectal cancer:
Pathologic results of the STAR-01 randomized phase III trial. J
Clin Oncol. 29:2773–2780. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Gérard JP, Azria D, Gourgou-Bourgade S,
Martel-Laffay I, Hennequin C, Etienne PL, Vendrely V, François E,
de La Roche G, Bouche O, et al: Comparison of two neoadjuvant
chemoradiotherapy regimens for locally advanced rectal cancer:
Results of the phase III trial ACCORD 12/0405-Prodige 2. J Clin
Oncol. 28:1638–1644. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Rödel C, Liersch T, Becker H, Fietkau R,
Hohenberger W, Hothorn T, Graeven U, Arnold D, Lang-Welzenbach M,
Raab HR, et al: Preoperative chemoradiotherapy and postoperative
chemotherapy with fluorouracil and oxaliplatin versus fluorouracil
alone in locally advanced rectal cancer: Initial results of the
German CAO/ARO/AIO-04 randomised phase 3 trial. Lancet Oncol.
13:679–687. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Park IJ, You YN, Agarwal A, Skibber JM,
Rodriguez-Bigas MA, Eng C, Feig BW, Das P, Krishnan S, Crane CH, et
al: Neoadjuvant treatment response as an early response indicator
for patients with rectal cancer. J Clin Oncol. 30:1770–1776. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Martens MH, Maas M, Heijnen LA, Lambregts
DM, Leijtens JW, Stassen LP, Breukink SO, Hoff C, Belgers EJ,
Melenhorst J, et al: Long-term outcome of an organ preservation
program after neoadjuvant treatment for rectal cancer. J Natl
Cancer Inst. 108(pii): djw1712016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Renehan AG, Malcomson L, Emsley R, Gollins
S, Maw A, Myint AS, Rooney PS, Susnerwala S, Blower A, Saunders MP,
et al: Watch-and-wait approach versus surgical resection after
chemoradiotherapy for patients with rectal cancer (the OnCoRe
project): A propensity-score matched cohort analysis. Lancet Oncol.
17:174–183. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kalady MF, de Campos-Lobato LF, Stocchi L,
Geisler DP, Dietz D, Lavery IC and Fazio VW: Predictive factors of
pathologic complete response after neoadjuvant chemoradiation for
rectal cancer. Ann Surg. 250:582–589. 2009.PubMed/NCBI
|
|
8
|
Russo AL, Ryan DP, Borger DR, Wo JY,
Szymonifka J, Liang WY, Kwak EL, Blaszkowsky LS, Clark JW, Allen
JN, et al: Mutational and clinical predictors of pathologic
complete response in the treatment of locally advanced rectal
cancer. J Gastrointest Cancer. 45:34–39. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zong C, Lu S, Chapman AR and Xie XS:
Genome-wide detection of single-nucleotide and copy-number
variations of a single human cell. Science. 338:1622–1626. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Armaghany T, Wilson JD, Chu Q and Mills G:
Genetic alterations in colorectal cancer. Gastrointest Cancer Res.
5:19–27. 2012.PubMed/NCBI
|
|
11
|
Kaz AM and Brentnall TA: Genetic testing
for colon cancer. Nat Clin Pract Gastroenterol Hepatol. 3:670–679.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Martin M: Cutadapt removes adapter
sequences from high-throughput sequencing reads. EMBnet J.
17:10–12. 2011. View Article : Google Scholar
|
|
13
|
Li H and Durbin R: Fast and accurate short
read alignment with Burrows-Wheeler transform. Bioinformatics.
25:1754–1760. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Li H, Handsaker B, Wysoker A, Fennell T,
Ruan J, Homer N, Marth G, Abecasis G and Durbin R; Genome Project
Data Processing S: The sequence alignment/map format and SAMtools.
Bioinformatics. 25:2078–2079. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
DePristo MA, Banks E, Poplin R, Garimella
KV, Maguire JR, Hartl C, Philippakis AA, del Angel G, Rivas MA,
Hanna M, et al: A framework for variation discovery and genotyping
using next-generation DNA sequencing data. Nature Genet.
43:491–498. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
16
|
Leung ML, Wang Y, Waters J and Navin NE:
SNES: Single nucleus exome sequencing. Genome Biol. 16:552015.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Gibson MK, Abraham SC, Wu TT, Burtness B,
Heitmiller RF, Heath E and Forastiere A: Epidermal growth factor
receptor, p53 mutation and pathological response predict survival
in patients with locally advanced esophageal cancer treated with
preoperative chemoradiotherapy. Clin Cancer Res. 9:6461–6468.
2003.PubMed/NCBI
|
|
18
|
Villafranca E, Okruzhnov Y, Dominguez MA,
García-Foncillas J, Azinovic I, Martinez E, Illarramendi JJ, Arias
F, Martinez Monge R, Salgado E, et al: Polymorphisms of the
repeated sequences in the enhancer region of the thymidylate
synthase gene promoter may predict downstaging after preoperative
chemoradiation in rectal cancer. J Clin Oncol. 19:1779–1786. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hao JJ, Yao HQ, Dai GY, Kang W, Jia XM, Xu
X, Cai Y, Zhan QM, Wang GQ and Wang MR: Chromosomal aneuploidies
and combinational fluorescence in situ hybridization probe panels
are useful for predicting prognosis for esophageal squamous cell
carcinoma. J Gastroenterol. 50:155–166. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Li Y, Zhang X, Ge S, Gao J, Gong J, Lu M,
Zhang Q, Cao Y, Wang DD, Lin PP, et al: Clinical significance of
phenotyping and karyotyping of circulating tumor cells in patients
with advanced gastric cancer. Oncotarget. 5:6594–6602. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Gao Y, Zhu Y, Zhang Z, Zhang C, Huang X
and Yuan Z: Clinical significance of pancreatic circulating tumor
cells using combined negative enrichment and
immunostaining-fluorescence in situ hybridization. J Exp Clin
Cancer Res. 35:662016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wu C, Hao H, Li L, Zhou X, Guo Z, Zhang L,
Zhang X, Zhong W, Guo H, Bremner RM, et al: Preliminary
investigation of the clinical significance of detecting circulating
tumor cells enriched from lung cancer patients. J Thorac Oncol.
4:30–36. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chen Z, Liu Z, Li W, Qu K, Deng X, Varma
MG, Fichera A, Pigazzi A and Garcia-Aguilar J: Chromosomal copy
number alterations are associated with tumor response to
chemoradiation in locally advanced rectal cancer. Genes Chromosomes
Cancer. 50:689–699. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Dumont P, Leu JI, Della Pietra AC III,
George DL and Murphy M: The codon 72 polymorphic variants of p53
have markedly different apoptotic potential. Nat Genet. 33:357–365.
2003. View
Article : Google Scholar : PubMed/NCBI
|
|
25
|
Johnstone RW, Ruefli AA and Lowe SW:
Apoptosis: A link between cancer genetics and chemotherapy. Cell.
108:153–164. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lin PP: Integrated EpCAM-independent
subtraction enrichment and iFISH strategies to detect and classify
disseminated and circulating tumors cells. Clin Transl Med.
4:382015. View Article : Google Scholar : PubMed/NCBI
|
